These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37063368)

  • 1. Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency.
    Mabondzo A; Harati R; Broca-Brisson L; Guyot AC; Costa N; Cacciante F; Putignano E; Baroncelli L; Skelton MR; Saab C; Martini E; Benech H; Joudinaud T; Gaillard JC; Armengaud J; Hamoudi R
    Front Mol Neurosci; 2023; 16():1118707. PubMed ID: 37063368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring.
    Broca-Brisson L; Disdier C; Harati R; Hamoudi R; Mabondzo A
    Front Neurosci; 2024; 18():1362497. PubMed ID: 38694899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency.
    Ullio-Gamboa G; Udobi KC; Dezard S; Perna MK; Miles KN; Costa N; Taran F; Pruvost A; Benoit JP; Skelton MR; Lonlay P; Mabondzo A
    Nanomedicine (Lond); 2019 Jun; 14(12):1579-1593. PubMed ID: 31038003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering neuronal deficit and protein profile changes in human brain organoids from patients with creatine transporter deficiency.
    Broca-Brisson L; Harati R; Disdier C; Mozner O; Gaston-Breton R; Maïza A; Costa N; Guyot AC; Sarkadi B; Apati A; Skelton MR; Madrange L; Yates F; Armengaud J; Hamoudi R; Mabondzo A
    Elife; 2023 Oct; 12():. PubMed ID: 37830910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dodecyl creatine ester therapy: from promise to reality.
    Mabondzo A; van de Kamp J; Mercimek-Andrews S
    Cell Mol Life Sci; 2024 Apr; 81(1):186. PubMed ID: 38632116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive deficits and increases in creatine precursors in a brain-specific knockout of the creatine transporter gene Slc6a8.
    Udobi KC; Kokenge AN; Hautman ER; Ullio G; Coene J; Williams MT; Vorhees CV; Mabondzo A; Skelton MR
    Genes Brain Behav; 2018 Jul; 17(6):e12461. PubMed ID: 29384270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism.
    Duran-Trio L; Fernandes-Pires G; Simicic D; Grosse J; Roux-Petronelli C; Bruce SJ; Binz PA; Sandi C; Cudalbu C; Braissant O
    Sci Rep; 2021 Jan; 11(1):1636. PubMed ID: 33452333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of myocytes and locomotion through
    Fernandes-Pires G; Azevedo MD; Lanzillo M; Roux-Petronelli C; Binz PA; Cudalbu C; Sandi C; Tenenbaum L; Braissant O
    Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101251. PubMed ID: 38745894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific vulnerability to metabolic failure: the crucial role of parvalbumin expressing neurons in creatine transporter deficiency.
    Ghirardini E; Sagona G; Marquez-Galera A; Calugi F; Navarron CM; Cacciante F; Chen S; Di Vetta F; Dadà L; Mazziotti R; Lupori L; Putignano E; Baldi P; Lopez-Atalaya JP; Pizzorusso T; Baroncelli L
    Acta Neuropathol Commun; 2023 Mar; 11(1):34. PubMed ID: 36882863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.
    Ghirardini E; Calugi F; Sagona G; Di Vetta F; Palma M; Battini R; Cioni G; Pizzorusso T; Baroncelli L
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine transporter-deficient rat model shows motor dysfunction, cerebellar alterations, and muscle creatine deficiency without muscle atrophy.
    Duran-Trio L; Fernandes-Pires G; Grosse J; Soro-Arnaiz I; Roux-Petronelli C; Binz PA; De Bock K; Cudalbu C; Sandi C; Braissant O
    J Inherit Metab Dis; 2022 Mar; 45(2):278-291. PubMed ID: 34936099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine Transporter Deficiency: Screening of Males with Neurodevelopmental Disorders and Neurocognitive Characterization of a Case.
    Thurm A; Himelstein D; DʼSouza P; Rennert O; Jiang S; Olatunji D; Longo N; Pasquali M; Swedo S; Salomons GS; Carrillo N
    J Dev Behav Pediatr; 2016 May; 37(4):322-6. PubMed ID: 27096572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.
    Farr CV; El-Kasaby A; Freissmuth M; Sucic S
    Front Synaptic Neurosci; 2020; 12():588954. PubMed ID: 33192443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
    Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
    J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the Creatine Transporter (Slc6a8) in Dopaminergic Neurons Leads to Hyperactivity in Mice.
    Abdulla ZI; Pahlevani B; Lundgren KH; Pennington JL; Udobi KC; Seroogy KB; Skelton MR
    J Mol Neurosci; 2020 Jan; 70(1):102-111. PubMed ID: 31520365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Gad2 specific Slc6a8 deletion recapitulates the contextual and cued freezing deficits seen in Slc6a8
    Sugimoto C; Perna MK; Regan SL; Tepe EA; Liou R; Fritz AL; Williams MT; Vorhees CV; Skelton MR
    Brain Res; 2024 Feb; 1825():148690. PubMed ID: 38030104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nervous System-Specific Model of Creatine Transporter Deficiency Recapitulates the Cognitive Endophenotype of the Disease: a Longitudinal Study.
    Molinaro A; Alessandrì MG; Putignano E; Leuzzi V; Cioni G; Baroncelli L; Pizzorusso T
    Sci Rep; 2019 Jan; 9(1):62. PubMed ID: 30635645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked creatine transporter deficiency results in prolonged QTc and increased sudden death risk in humans and disease model.
    Levin MD; Bianconi S; Smith A; Cawley NX; Do AD; Hammond D; Grafstein JF; Thurm A; Miller J; Perreault J; Noguchi A; Springer D; Kozel BA; Spurney CF; Wassif CA; Yu ZX; Schulze A; Porter FD; Hannah-Shmouni F
    Genet Med; 2021 Oct; 23(10):1864-1872. PubMed ID: 34050321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases.
    Dunbar M; Jaggumantri S; Sargent M; Stockler-Ipsiroglu S; van Karnebeek CD
    Mol Genet Metab; 2014 Aug; 112(4):259-74. PubMed ID: 24953403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA sequencing of creatine transporter (SLC6A8) deficient fibroblasts reveals impairment of the extracellular matrix.
    Nota B; Ndika JD; van de Kamp JM; Kanhai WA; van Dooren SJ; van de Wiel MA; Pals G; Salomons GS
    Hum Mutat; 2014 Sep; 35(9):1128-35. PubMed ID: 24962355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.